Compositions and methods of treating root avulsion injury

US10258672B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10258672-B2
Application numberUS-201615274236-A
CountryUS
Kind codeB2
Filing dateSep 23, 2016
Priority dateOct 9, 2014
Publication dateApr 16, 2019
Grant dateApr 16, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of treating root avulsion injury in a subject in need thereof includes administering to the subject a therapeutic agent that inhibits one or more of catalytic activity, signaling, and function of PTPσ.

First claim

Opening claim text (preview).

Having described the invention, we claim: 1. A method of treating root avulsion injury in a subject in need thereof, the method comprising: administering to the subject a therapeutic agent that inhibits one or more of catalytic activity, signaling, and function of PTPσ, wherein the therapeutic agent comprises a therapeutic peptide, the therapeutic peptide including an amino acid sequence selected from the group consisting of SEQ ID NO: 32 and SEQ ID NO: 63. 2. The method of claim 1 , the therapeutic agent comprising a therapeutic peptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NO: 32 and SEQ ID NO: 63. 3. The method of claim 1 , wherein the therapeutic agent includes a transport moiety that is linked to the therapeutic peptide and facilitates uptake of the therapeutic peptide by a nerve cell being treated. 4. The method of claim 3 , wherein the transport moiety is an HIV Tat transport moiety. 5. The method of claim 3 , wherein the therapeutic agent is administered systemically to the subject being treated. 6. The method of claim 1 , further comprising connecting an avulsed end in a peripheral nerve to a portion of the central nervous system. 7. The method of claim 1 , wherein the therapeutic agent is administered at an amount effective to increase survival rate of injured motoneurons, enhance regrowth across inhibitory central nervous system scar into re-implanted spinal roots, regenerate axons, decrease muscle atrophy, and/or promote motor functional recovery.

Assignees

Inventors

Classifications

  • Protein-tyrosine-phosphatase (3.1.3.48) · CPC title

  • Cytokines; Lymphokines; Interferons · CPC title

  • Enzyme inhibitors (protease inhibitors A61K38/55) · CPC title

  • A61K38/465Primary

    acting on ester bonds (3.1), e.g. lipases, ribonucleases · CPC title

  • Antigen-pulsed cells, e.g. T-cells · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10258672B2 cover?
A method of treating root avulsion injury in a subject in need thereof includes administering to the subject a therapeutic agent that inhibits one or more of catalytic activity, signaling, and function of PTPσ.
Who is the assignee on this patent?
Univ Case Western Reserve, Univ Hong Kong
What technology area does this patent fall under?
Primary CPC classification A61K38/465. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).